Theralase Technologies Inc. announced that it is advancing on its sales and marketing mandate through the hiring of Mr. Derek Small as Director of Sales and Marketing. Mr. Small has over fifteen years of experience in the sale and marketing of medical devices in Canada and the US.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.19 CAD | 0.00% |
|
-2.56% | +8.57% |
12/06 | Theralase Technologies Inc. Announces Rutherrin Increases Efficacy of Chemotherapy | CI |
10/06 | Theralase Technologies Inc. Announces Ruvidar Enhances Efficacy of Cancer Drug | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.57% | 3.31Cr | |
-4.15% | 81Cr | |
-28.52% | 22Cr | |
+10.73% | 6.19Cr |
- Stock Market
- Equities
- TLT Stock
- News Theralase Technologies Inc.
- Theralase Technologies Inc. Hires Mr. Derek Small as Director of Sales and Marketing